NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Tuesday that its revenues in the first quarter increased 14 percent year over year. 

For the three months ended March 31, the San Diego-based cell-free molecular diagnostics firm recorded $127,000 in total revenues, up from $111,000 in the year-ago quarter, easily beating analysts' average estimate of $80,000. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.